All
Exercise: The Best Weapon Against Post-Cancer Fatigue
Health professionals have always touted the benefits of exercise, but what role, if any, does exercise play in helping fighting post-cancer fatigue?
Predicting HPV+ Oropharyngeal Cancer Recurrence With Novel Biomarker
There is a need to find biomarkers that may help predict recurrence in HPV+ oropharyngeal cancer, says Matthew E. Spector, M.D.
Antidiabetic Agent Linked to Increased Risk of Bladder Cancer
The FDA recently issued a warning that a type of medicine used to treat Type 2 diabetes may increase a person's risk for developing bladder cancer.
Program Opens to Expand Patient Access to Niraparib for Ovarian Cancer
An expanded access program (EAP) was just opened up for ceratain patients with ovarian cancer to receive niraparib.
Pivotal Trial Finds That Imbruvica Shows Benefit in CLL and SLL
Imbruvica (ibrutinib) improved survival for patients with small lymphocytic lymphoma (SLL) and chronic lymphocytic leukemia (CLL), according to study results that were recently presented.
Individualized Treatment Is Needed for mCRC Subset
CURE spoke with Maria Ignez Braghiroli, M.D. about the need for individualized treatment for patients with NRAS-mutant metastatic colorectal cancer.
Tweet Chat: The Community of Cancer and The Language They Use
On January 19, we'll be co-hosting a tweet chat with Oncology Nursing News and Jen Sotham about the phrases and language used by the cancer community. Join us at 9 p.m. EST with the hashtag #CureConnect
Irregular Menstrual Cycles May Offer Insight to Ovarian Cancer Risk
A recent study examined the relationship between polycystic ovarian syndrome, long or irregular periods and ovarian cancer risk.
The Art of Acceptance After Cancer
After a bout with cancer, many things change. Quite a few of those things are changes that can never be changed back to the way it used to be. So, how does one go about learning acceptance?
Fighting Back: Regaining Control After Cancer
Kim Johnson discusses making better choices in the face of the unknown after cancer.
Study Examines Factors Contributing to "Chemobrain" in Patients With Breast Cancer
A large study at the University of Rochester Medical Center’s Wilmot Cancer Institute sought out to get to the root of the causes of cancer-related cognitive impairment and who may be at risk.
Patient Anxiety Influences Prostate Cancer Treatment Decisions
A team of researchers at the University of Buffalo investigated the role that patients' stress and anxiety plays in deciding on treatment.
Discussing the World Health Organization's New Brain Tumor Classification
The World Health Organization (WHO) reclassified some types of brain cancers, giving a clearer outline on how to treat them.
FDA Warns Against So-Called "Cancer Cure"
The FDA recently warned consumers about PNC-27, a non-approved "treatment" for cancer.
Vaccine Shows Benefit in Early-Stage Breast Cancer
Brian J. Czerniecki, M.D., Ph.D., discusses a promising vaccine for certain patients with breast cancer.
Tips for a New Year of Health for the Cancer Survivor
While there is a difference between cancer and mundane medical crises, the mundane counts. Try to be holistic. Survive flu season as well as cancer. Practice wellness.
Tossing Out the Cancer Paperwork: Is It Even Safe?
Breast cancer and melanoma survivor who is also a clutter-clearing author shares her tips for cancer and other papers.
SPOHNC Focuses on Support for Oral, Head and Neck Cancer
From publications to one-on-one interactions, SPOHNC offers caregivers, patients and survivors of oral, head and neck cancer support they need to navigate their diagnosis.
Changing the Frontline Treatment of Kidney Cancer
After the approvals of agents in the second-line setting, researchers are now turning to improving the frontline treatment of kidney cancer.
Chemotherapy Remains a Mainstay in Advanced Prostate Cancer
Chemotherapy agents such as docetaxel will remain a crucial part of treating patients with advanced prostate cancer, says William Oh, M.D.
4 Tips on What I Wish I Did After My Cancer Diagnosis
Because I am a lifelong learner and an educator at heart, I always feel the compelling need to share in case someone else out there might benefit from the fires I've walked through.
Expert Looks Ahead in the Treatment of MPNs
Michael J. Mauro, M.D., discusses advances in treating myeloproliferative disorders.
Understanding the Language of Cancer Clinical Trials
Patients' levels of health literacy often correlate to their understanding of clinical trial randomization, which has an effect on enrollment.
Frontline Keytruda Gains Priority Review for Lung Cancer
A Keytruda was recently granted a priority review to a supplemental biologics license application to treat patients with metastatic or advanced non-small cell lung cancer.
Additional Chemo
Although now in remission, Ed has agreed with the oncologist, to take two more rounds of chemo in hopes he might not have another relapse.
It's OK to Be Alive: Learning to Deal With Cancer Survivor's Guilt
Accepting feelings of guilt is not only normal, but it's a part of life.
Stigma and Lung Cancer
An article recently published in a special issue of CURE focused on lung cancer, “Quitting Smoking Is Possible and Reduces Cancer Risk,” has generated discussion on social media and in our Discussion Forum.
Expert Discusses Targetable Mutations and New Agents in Lung Cancer
New advancements are quickly advancing the treatment landscape of lung cancer.
Tecentriq Gets FDA Priority Review for New Use In Bladder Cancer
Tecentriq (atezolizumab) is being reviewed for the use in additional settings to treat bladder cancer.
Finding Focus In the New Year With Cancer
Living resolution-free has given me a chance to really think about what matters now and how I want to live.
